WNT1 and neoplasm: Together, these data suggest that dormant residual disease in the HER2/neu model may be enriched for tumor cells that have undergone epithelial-to-mesenchymal transition (EMT), whereas dormant residual disease in the Wnt1 model may be enriched for tumor cells with a basal epithelial phenotype.